Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study

OBJECTIVE: Gaucher disease (GD) is a lysosomal storage disease characterized by a deficiency of glucocerebrosidase. Although enzyme‐replacement and substrate‐reduction therapies are available, their efficacies in treating the neurological manifestations of GD are negligible. Pharmacological chaperon...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Clin Transl Neurol
Egile Nagusiak: Narita, Aya, Shirai, Kentarou, Itamura, Shinji, Matsuda, Atsue, Ishihara, Akiko, Matsushita, Kumi, Fukuda, Chisako, Kubota, Norika, Takayama, Rumiko, Shigematsu, Hideo, Hayashi, Anri, Kumada, Tomohiro, Yuge, Kotaro, Watanabe, Yoriko, Kosugi, Saori, Nishida, Hiroshi, Kimura, Yukiko, Endo, Yusuke, Higaki, Katsumi, Nanba, Eiji, Nishimura, Yoko, Tamasaki, Akiko, Togawa, Masami, Saito, Yoshiaki, Maegaki, Yoshihiro, Ohno, Kousaku, Suzuki, Yoshiyuki
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2016
Gaiak:
Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4774255/
https://ncbi.nlm.nih.gov/pubmed/27042680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.292
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak